Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.

Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders

Vollenweider, Franz X., Preller, Katrin H. · 2020 · Nature Reviews Neuroscience

Abstract

Renewed interest in the use of psychedelics in the treatment of psychiatric disorders warrants a better understanding of the neurobiological mechanisms underlying the effects of these substances. After a hiatus of about 50 years, state-of-the art studies have recently begun to close important knowledge gaps by elucidating the mechanisms of action of psychedelics with regard to their effects on receptor subsystems, systems-level brain activity and connectivity, and cognitive and emotional processing. In addition, functional studies have shown that changes in self-experience, emotional processing and social cognition may contribute to the potential therapeutic effects of psychedelics. These discoveries provide a scientific road map for the investigation and application of psychedelic substances in psychiatry.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41583-020-0367-2

Cites

188 of 188 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 188 references

Research works printed but not linked: 3

  1. Leuner, H. in 50 Years of LSD: Current Status and Perspectives of Hallucinogens: a Symposium of the Swiss Academy of Medical Sciences (eds Pletscher, A. & Ladewig, D.) 175–189 (Parthenon Publisher Group Ltd, 1994).
  2. Pletscher, A. & Ladewig, D. 50 Years of LSD: Current Status and Perspectives of Hallucinogens: A Symposium of the Swiss Academy of Medical Sciences (Parthenon Publisher Group Ltd, 1994).
  3. Leysen, J. E. in Neuromethods (eds Boulton, A. A., Baker, G. B. & Butterworth, R.) 299–350 (Springer, 1989).

Cited by

See all 570

Metadata

Authors
Vollenweider, F. X., & Preller, K. H.
Affiliations
University Hospital Zurich (CH)
Venue
Nature Reviews Neuroscience
Published
2020-09-14
Volume
21
Issue
11
Pages
611-624
ISSN
  • 1471-003X (ISSN-L)
  • 1471-0048
OpenAlex
W3085641834
Cited by
570
References
188
Citations by year
2026: 106 · 2025: 105 · 2024: 118 · 2023: 96 · 2022: 80 · 2021: 60 · 2020: 5
FWCI
4.76
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Nature reviews. Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
psychedelics, psychedelic therapy, mental illness, receptor systems, brain connectivity, cognitive processes, emotional processing, social cognition, self-experience, therapeutic mechanisms
MeSH terms
Delta Catenin, Animals, Mental Disorders, Brain, Emotions, Hallucinogens, Humans, Neurons, Receptors, Serotonin, Self Concept, Catenins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders. https://app.cochat.ai/papers/10.1038/s41583-020-0367-2
The paper
Vollenweider, F. X., & Preller, K. H. (2020). Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders. Nature Reviews Neuroscience. https://doi.org/10.1038/s41583-020-0367-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.